Saturday, Jul 04, 2020 | Last Update : 10:02 PM IST

102nd Day Of Lockdown

Maharashtra1929901046878376 Tamil Nadu102721583781385 Delhi94695656242923 Gujarat34686249411905 Uttar Pradesh2579717597749 West Bengal2048813571717 Telangana2046210195283 Karnataka197108807293 Rajasthan1925615352443 Andhra Pradesh176998008218 Haryana1550911019251 Madhya Pradesh1410610815589 Bihar11457848888 Assam9800632814 Jammu and Kashmir76954856105 Odisha7316535333 Punjab56683989149 Kerala4594243626 Chhatisgarh3065241414 Uttarakhand2791190937 Jharkhand2339160512 Tripura140110931 Manipur13166390 Goa11984783 Himachal Pradesh9796179 Puducherry73930112 Nagaland5351820 Chandigarh4593956 Arunachal Pradesh252751 Mizoram1601230 Sikkim101520 Meghalaya50421
  World   Americas  26 May 2020  WHO suspends testing hydroxychloroquine on virus patients

WHO suspends testing hydroxychloroquine on virus patients

REUTERS
Published : May 26, 2020, 12:16 pm IST
Updated : May 26, 2020, 12:16 pm IST

Hydroxycholoroquine has been touted by Donald Trump and many others as a possible treatment for COVID-19

A chemist holds a pack of hydroxychloroquine tablets in Mumbai, India. (AP)
 A chemist holds a pack of hydroxychloroquine tablets in Mumbai, India. (AP)

Geneva: The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.

Hydroxychloroquine has been touted by Donald Trump and many others as a possible treatment for the disease caused by the novel coronavirus. The U.S. President has said he was taking the drug to help prevent infection.

 

“The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board,” Tedros told an online briefing.

He said the other arms of the trial - a major international initiative to hold clinical tests of potential treatments for the virus - were continuing.

The WHO has previously recommended against using hydroxychloroquine to treat or prevent coronavirus infections, except as part of clinical trials.

Dr Mike Ryan, head of the WHO emergencies programme, said the decision to suspend trials of hydroxychloroquine had been taken out of “an abundance of caution”.

Tags: hydroxychloroquine, coronavirus, covid-19, trump, world health organization, malaria drug, india